Taylor Daphne 4
4 · Aptevo Therapeutics Inc. · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Taylor Daphne L
SVP, CFO
Transactions
- Award
Restricted Stock Unit
2023-03-03+11,000→ 11,000 total→ Common Stock (11,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-03-04−1,583→ 3,167 total→ Common Stock (1,583 underlying) - Exercise/Conversion
Common Stock
2023-03-04+1,583→ 5,423 total - Award
Stock Option (right to buy)
2023-03-03+11,000→ 11,000 totalExercise: $2.15Exp: 2033-03-02→ Common Stock (11,000 underlying)
Footnotes (4)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]The option vests in three approximately equal annual installments beginning on March 2, 2024.
- [F3]The RSUs vest in three approximately equal annual installments beginning on March 2, 2024.
- [F4]On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.